Ratings Moves: ING,...
Health Care: Drugs
BioTime Inc. (BTIM: AMEX)
$8.13 -0.10 | -1.22%
01/27/11 - 04:04 PM ET
82.50K / 168.80K
Vol / Avg. Vol:8.23 / 8.23
Open / Prev. Close:8.10 - 8.41
Today's Range:5.55 - 9.94
52 Wk Range:36.41%
Performance YTD:TheStreet Rating:
Portfolios with BTIM
- Portfolio NameUser Type
- UserNest Egg Investing
- UserManielse's Holdings
- Userpetekni Portfolio 1
- UserScott Seeger Simon
Latest BTIM Headlines from TheStreet
- Stocks Under $5 Least Likely to Go Bankrupt 09.16.10 | 06:09 am
- Scientists cheer Obama's stem cell reversal 03.10.09 | 03:03 am
Press Releases for BTIM
- BioTime Expands Corporate Headquarters - Business Wire 10.26.10 | 09:10 am
- BioTime’s CEO Michael West Presents 12 New ACTCellerateTM Cell Lines And New PureStemTM Products Slated For Launch In 2011 At GTCbio Stem Cell Conference Today - Business Wire 10.22.10 | 09:10 am
- BioTime’s CEO Michael West To Speak At GTCbio And Unveil 12 New Diverse Cell Lines To Be Launched November 1, 2010 - Business Wire 10.14.10 | 09:10 am
- BioTime Announces Stock Ticker Symbol Change And Extension Of Warrant Expiration Date - Business Wire 10.12.10 | 08:10 am
- Cell Cure Neurosciences Ltd., A Subsidiary Of BioTime, Inc. And Hadasit Bio Holdings Ltd., Enters Into An Exclusive License Option Agreement With Teva Pharmaceutical Industries Ltd. - Business Wire 10.10.10 | 09:10 pm
- Cell Cure Neurosciences’ Shareholders Will Invest $7.1 M In The Company’s Development Of Innovative Stem Cell Treatments For Neural And Retinal Diseases - Business Wire 10.10.10 | 09:10 pm
- BioTime CEO Dr. Michael West And CMO Dr. David Jin To Present Keynote Addresses At The Sixth Chinese Congress In Regenerative Medicine And Stem Cell Therapy In Suzhou, P.R. China - Business Wire 09.16.10 | 08:09 am
- BioTime CEO Dr. Michael West To Present At Stem Cells USA & Regenerative Medicine Congress 2010 - Business Wire 09.13.10 | 08:09 am
- BioTime Announces Executive Management Changes - Business Wire 09.08.10 | 11:09 pm
- BioTime To Launch Seven New Embryonic Progenitor Cell Lines On September 1, 2010 - Business Wire 08.26.10 | 03:08 pm
Partner Headlines for BTIM
- Aspen / Sigma Lead a Busy Week of Biotech Deals - Seeking Alpha 08.22.10 | 09:08 am
